retatrutide same as ozempic (“reta”) is an experimental weight-loss drug currently in Phase 3 clinical trials. It's a once-weekly injection similar to and Mounjaro—but more powerful. The reason comes down to how it works Doctor Ranks The Most Powerful

Here is the complete UK research guide

B., Nuhoho, S., Ali, S

GLP-1-based therapy was developed in the 1990s and treatment with daily injectable GLP-1 receptor agonists and oral dipeptidyl peptidase-4 (DPP-4) inhibitors was introduced in the 2000s [2]

Novo Nordisk makes both Tresiba and Ozempic (semaglutide)

A critical factor complicating this translation is the significant heterogeneity in methodological variables (including the choice of animal species, model type, and ischemia duration) across preclinical studies

Fever, chills, or feeling generally unwell following the injection may indicate a systemic infection and necessitate urgent evaluation